Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
Jeffrey F. Ohren(Pfizer (United States)), Huifen Chen(Pfizer (United States)), A.G. Pavlovsky(Pfizer (United States)), Christopher E. Whitehead(Pfizer (United States)), Erli Zhang(Pfizer (United States)), Peter Kuffa(AstraZeneca (United States)), Chunhong Yan(Pfizer (United States)), Patrick McConnell(Pfizer (United States)), Cindy Spessard(Pfizer (United States)), Craig Banotai(Pfizer (United States)), W. Thomas Mueller(Pfizer (United States)), Amy M. Delaney(Pfizer (United States)), Charles A. Omer(University of Michigan–Ann Arbor), Judith S. Sebolt–Leopold(Pfizer (United States)), David T. Dudley(Pfizer (United States)), Iris Leung(Pfizer (United States)), Cathlin Flamme(Pfizer (United States)), Joseph S. Warmus(Pfizer (United States)), Michael D. Kaufman(Pfizer (United States)), Stephen D. Barrett(Pfizer (United States)), Haile Tecle(Pfizer (United States)), Charles A. Hasemann(Pfizer (United States))
Cited by 619
Abstract
Related Papers
No related papers found
Powered by citation graph analysis